FDA Approved: PREGABALIN — Supplemental Application (MARKSANS PHARMA LIMITED)

View source ↗

Summary

FDA approved a supplemental application for pregabalin submitted by Marksans Pharma Limited (ANDA 216197).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Partial-onset Seizures
• Postherpetic Neuralgia
• Spinal Cord Injury Pain

Drugs mentioned

• Pregabalin (generic) (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)